Jazz Pharmaceuticals Plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jazz Pharmaceuticals Plc with three other
pharmaceutical manufacturers in Europe:
Hikma Pharmaceuticals PLC
of the United Kingdom
sales of £1.56 billion [US$1.92 billion]
of which 40%
was Injectable Pharmaceuticals),
Vifor Pharma AG
(1.58 billion Swiss Francs [US$1.60 billion]
of which 100%
was Pharmaceutical), and
Croda International Plc
based in the United Kingdom
(£1.39 billion [US$1.71 billion]
of which 35%
was Personal Care).
During the year ended December of 2018, sales at
Jazz Pharmaceuticals Plc were 1.60 billion Euro (US$1.77 billion).
increase of 12.9%
versus 2017, when the company's sales were 1.42 billion Euro.
This was the fifth consecutive year of sales increases at Jazz Pharmaceuticals Plc
(and since 2013, sales have increased a total of 145%).